全EXOME定序市场规模、份额和成长分析（按产品、技术、工作流程、应用、最终用途和地区）- 产业预测 2025-2032

预计 2023 年全球全EXOME定序市场规模将达到 4.9688 亿美元，并将从 2024 年的 5.8334 亿美元成长至 2032 年的 21.0506 亿美元，预测期内复合年增长率为 1.4%（ 2025-2032年），预计复合年增长率为17.4%。

整个EXOME定序市场正在经历强劲成长，这得益于促进早期和准确检测遗传和慢性疾病的技术进步。研究和诊断领域的新应用加上成本的下降，大大推动了个人化医疗解决方案的需求。医疗保健专业人员现在正在使用全外EXOME定序来识别基因突变、为个别患者提供个人化治疗并改善临床结果。华大基因与中国医疗服务提供者的合作，凸显了这些服务的可近性日益提高。值得注意的是，Natera 获得 FDA 认可的突破性设备 Signatera 等创新技术彰显了EXOME定序在癌症诊断和监测方面的变革潜力。随着个人化医疗的普及，市场将随着新诊断方法和新技术的出现而不断扩大。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全EXOME定序市场规模（依产品）

• 市场概况
• 装置
• 耗材
• 系统
• 套件
• 服务

全EXOME定序市场规模（依技术）

• 市场概况
• 合成定序
• 离子半导体序列
• 其他的

全EXOME定序市场规模（依工作流程）

• 市场概况
• 前序
• 顺序
• 资料分析

全EXOME定序市场规模（依应用）

• 市场概况
• 临床诊断
• 药物研发
• 个人化医疗
• 农业和动物研究
• 其他的

全EXOME定序市场规模（依最终用途）

• 市场概况
• 学术研究所
• 医院和诊所
• 製药和生物技术公司
• 其他的

全EXOME定序市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Pacific Biosciences of California, Inc.（PacBio）（USA）
• Oxford Nanopore Technologies plc.（UK）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（USA）
• Novogene Co., Ltd.（China）
• Azenta, Inc.（formerly GENEWIZ）（USA）
• CD Genomics（USA）
• Psomagen, Inc.（South Korea）
• F. Hoffmann-La Roche AG（Switzerland）
• 10x Genomics, Inc.（USA）
• Bionano Genomics, Inc.（USA）
• Dante Labs（Italy）
• MGI Tech Co., Ltd.（China）
• GeneDx Holdings Corp.（USA）
• Helix OpCo, LLC（USA）

结论和建议

Global Whole Exome Sequencing Market size was valued at USD 496.88 million in 2023 and is poised to grow from USD 583.34 million in 2024 to USD 2105.06 million by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The market for whole exome sequencing is experiencing robust growth driven by advancements in technology that facilitate early and accurate detection of genetic and chronic diseases. New applications in research and diagnostics, coupled with decreasing costs, have significantly increased demand for personalized medical solutions. Medical professionals now leverage whole exome sequencing to identify genetic variations and tailor treatments to individual patients, enhancing clinical outcomes. Collaborations, such as the partnership between a Chinese healthcare provider and BGI Genomics, underscore the rising accessibility of these services. Notably, innovations like Natera's FDA-designated breakthrough device, Signatera, exemplify the transformative potential of exome sequencing in cancer diagnosis and monitoring. As personalized medicine gains traction, the market is poised for continued expansion with emerging diagnostics and technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segmental Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A key factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans that align with the patient's specific genetic profile and risk of disease. This bespoke approach not only enhances the efficacy of therapies but also promotes better patient outcomes. The continued advancements in sequencing technologies and data analysis capabilities have made whole exome sequencing increasingly accessible and cost-effective, thus encouraging its implementation in clinical environments. As the emphasis on personalized healthcare continues to grow, so does the demand for whole exome sequencing, shaping the future landscape of medical treatment.

Restraints in the Global Whole Exome Sequencing Market

A notable constraint impacting the global whole exome sequencing market is the challenges tied to data complexity and interpretation. The considerable volume of genomic data produced presents significant difficulties in analysis, necessitating extensive expertise and time. Ensuring that the results are both accurate and reliable is essential for making sound medical decisions. The reliance on advanced bioinformatics tools and qualified personnel for effective data handling and interpretation limits the broader adoption of whole exome sequencing. Consequently, this factor restricts its accessibility and feasibility in various healthcare environments, hindering the implementation of this innovative technology.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is witnessing a significant trend driven by the integration of artificial intelligence (AI) and machine learning (ML) algorithms into data analysis and interpretation processes. This innovative approach is transforming how vast amounts of genomic data generated through whole exome sequencing are processed, enabling more efficient identification of genetic variations and disease associations. By automating data handling, AI and ML improve accuracy and efficiency in genomic analysis, thus facilitating faster, precise diagnoses and personalized treatment strategies. As these technologies continue to evolve, they are set to revolutionize genomic medicine, underscoring their critical role in shaping the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• System
• Kits
• Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Agriculture and Animal Research
• Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic And Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global Whole Exome Sequencing Market Size & CAGR (2025-2032)

• North America (Product, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Workflow, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (PacBio) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc. (formerly GENEWIZ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dante Labs (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI Tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx Holdings Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helix OpCo, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations